Effects of Green Tea on Cardiometabolic Outcomes
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Green tea, Placebo.
- Who it may be relevant to
- Registry conditions: Cardiometabolic Syndrome. Basic parameters: 18 years — 65 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United Kingdom
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Effects of Green Tea Supplementation on Cardiometabolic Parameters
Overview
Cardiovascular disease, type 2 diabetes mellitus and associated diseases combined are the leading health burden and cause of mortality worldwide; therefore, the necessity for an intervention is paramount. Dietary interventions to improve cardiometabolic health are highly sought after as they possess less risk than pharmacological drugs. It has been postulated that Green tea may be beneficial in improving cardiometabolic outcomes. However, to date, no research has explored this using a placebo randomized intervention.
Interventions
- Dietary supplement Green tea
Green tea tablets 1000mg 1 x per day - Other Placebo
Placebo control 1 x blinded placebo tablet per day
Primary outcome measures
- Systolic blood pressure [Time frame: Baseline]
- Systolic blood pressure [Time frame: 20 days]
Secondary outcome measures (12)
- Diastolic blood pressure [Time frame: Baseline]
- Diastolic blood pressure [Time frame: 20 days]
- Percent bodyfat [Time frame: Baseline]
- Percent bodyfat [Time frame: 20 days]
- Waist to hip ratio [Time frame: Baseline]
- Waist to hip ratio [Time frame: 20 days]
- Blood glucose [Time frame: Baseline]
- Blood glucose [Time frame: 20 days]
- Blood triglycerides [Time frame: Baseline]
- Blood triglycerides [Time frame: 20 days]
- Triglyceride glucose index [Time frame: Baseline]
- Triglyceride glucose index [Time frame: 20 days]
Eligibility criteria
Inclusion criteria
- Healthy
- Between 18 \& 65 years
- Non-smoker
- BMI < 30
- Able to give informed consent
Exclusion criteria
- Pregnancy
- Diabetes or any other metabolic/ uncontrolled hypertensive conditions
- Food allergies to quercetin
- Habitual consumption of quercetin
- Not regularly taking medication or antioxidant supplements
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Double blind
- Primary purpose
- Prevention
Study locations
United Kingdom · 1 center
- University of Central Lancashire — Preston
Identifiers
NCT: NCT06795438 · Green tea cardiometabolic